Clinical trials
Observational Lymphoma, Follicular trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Italiana Linfomi - ETS | 3 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| AbbVie | 1 |
| Andrés José Maria Ferreri | 1 |
| Associazione Angela Serra per la ricerca sul cancro | 1 |
| Bristol-Myers Squibb | 1 |
| European Hematology Association - Lymphoma Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hoffmann-La Roche | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 17 |
| Lymphoma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Leukemia, Hairy Cell | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Mycosis Fungoides | 2 |
| Blast Crisis | 1 |
| Breast Carcinoma In Situ | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.